Other
Corona Virus Infection
5
Pipeline Programs↗
1
Active Trials↗
5
Companies Involved↗
Corona Virus Infection is an early-stage landscape with 5 programs across 5 companies. The most active players are Gilead, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, EMD Serono. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 35
Approved
No programs
Analysis
Trial Status
9
clinical trials
Unknown status4 · 44%
Completed3 · 33%
Terminated1 · 11%
Recruiting1 · 11%
Clinical Trials
Trial Activity
9 trials
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Completed·IInstitut National de la Santé Et de la Recherche Médicale, France·Phase 3·NCT04315948·1,552 enrolled
A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
Unknown status·—·Phase 3·NCT04282902·294 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)